Summary A cDNA library constructed from mRNA from a human breast carcinoma metastasis was screened with a polyclonal antibody to deglycosylated human milk fat globule membrane, resulting in the isolation of eight clones from a total of 105 plaques. One of these (J16) was identified as lactoferrin. It was highly expressed (as a 2.5 Kb mRNA) in lactating breast and in both normal resting tissue taken from adjacent to carcinoma or from reduction mammoplasties. Immunoreactive lactoferrin was localised to ductal cells and their secretions in both normal and mildly hyperplastic ducts. In a normal tissue screen J16 was highly expressed in stomach, poorly in skin and lymphocytes and absent from other organs examined. It was variably expressed in 33/59 invasive primary breast tumours; lactoferrin protein in these was heterogeneously distributed in epithelial tumour foci. Presence of J16 was inversely related to expression of oestrogen receptor protein (P = 0.0001). There was no significant relationship to other clinical parameters. We also found immunoreactivity in 20/41 (49%) cases of ductal carcinoma in situ. Expression was not observed in any breast or gastric cell line examined. Thus lactoferrin appears to be down regulated in some forms of cancer. The presence of lactoferrin could be a contraindication for effective endocrine therapy.
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Changes in cell surface or associated antigens are implicated both in normal cellular processes such as differentiation and immunodetermination, and in the phenotypic expression of neoplasia (Reisfeld & Cheresh 1987; Sulitizeanu, 1985) .
Identification of susceptible epitopes would further our understanding of malignant progression and could provide potential targets with clinical applications. The human milk fat globule membrane (HMFGM), derived from the luminal epithelial cell surface shed into breast milk is well established as a source of breast glycoproteins.
By extending previous approaches, we have used polyclonal antisera, raised against carbohydrate depleted HMFGM (Gendler et al., 1987) to immunoscreen a cDNA phage expression library (Young & Davis, 1983) constructed from human breast carcinoma metastasis mRNA. One of the immunoreactive clones isolated (Campbell et al., 1990) was identified as encoding part of the recently sequenced lactoferrin gene (Rado et al., 1987; Powell & Ogden, 1990) . A major component of human milk, lactoferrin has been shown to be regulated in mouse uterus and mammary gland by oestradiol and prolactin respectively (Teng et al., 1989) . Although reported to be widely distributed in murine tissues, its expression appears to be more limited in human tissues, predominantly to the glandular organs (Mason & Taylor, 1978) . In human breast carcinomas, previous immunocytochemical studies Cell culture The human breast cell lines (Engel & Young, 1978) were maintained in Dulbecco's minimum essential medium containing phenol red, supplemented with 10% foetal calf serum and antibiotics. The HbL 100 and HBrSVI.6.I lines were from Dr M. O'Hare, the 184AI and 184B5 from Dr M. Stampfer and the others, MCF7, T47D, ZR75-1 and MDA-231 as previously indicated (Skilton et al., 1989 (Skilton et al., 1989) . Non-breast normal tissues were either collected fresh from operating theatres at St George's or in some cases were from post-mortem material. Archival paraffin embedded materal was from the pathology departments of the above hospitals, and the blocks containing DCIS were kindly made available by Mr J.C. Gazet. This latter series of patients were subdivided using established histological criteria into groups exhibiting cribriform, comedo, solid or micropapillary DCIS (Page et al., 1987) . In some cases, more than one type was recorded on the same section. Only those with no evidence of invasive carcinoma were included in this part of the study.
Preparation and deglycosylation of human milk fat globule membrane Milk from mothers 1-7 days post partum was processed as described (Gore et al., 1984) for deglycosylation using trimethanesulphonic acid. The final HMFGM pellet was diluted at least three times with 10 mM Tris-HCI pH 7.5 containing 5 mM Phenylmethylsulfonyl fluoride, and centrifuged at 140,000 g for 1.5 h at 4°C. The membrane fractions were stored in aliquots at -40°C.
Protein content was assayed with Bio-Rad protein dye reagent (Bradford, 1976 (Gore et al., 1984) against CHO-HMFGM. Serum (R2) was prepared and stored in 100 jIl aliquots at -30°C.
Characterisation of antisera to carbohydrates stripped human milk fat globule membrane ELISA R2 antisera was tested using an ELISA (Gore et al., 1984) Immunohistochemistry with R2 Sections from methacarn fixed, paraffin embedded normal breast, primary breast carcinoma and other normal tissues were stained with R2 antisera to CHO-HMFGM (diluted to 1:500 in PBS/1% BSA) using an alkaline phosphatase linked goat anti-rabbit IgG secondary antibody and standard protocols (Foster et al., 1982) .
Immunoblotting 100 lAg of CHO-HMFGM were separated on a 10% PAGE/ SDS gel (Laemmli, 1970) and proteins transferred electrophoretically to nitrocellulose (Burnette, 1981) . Binding of primary antibody was detected with a goat anti-rabbit IgG horseradish peroxidase conjugate (Bio-Rad, Watford, United Kingdom).
cDNA library construction Total RNA was extracted (Chirgwin et al., 1979 ) from a breast metastatic lymph node and poly A + selected by standard oligo dT chromatography. cDNA was synthesised using the S1 nuclease method (Huynh et al., 1985) and inserted into the expression vector lambda gtl 1 using EcoRI linkers. Following packaging the library of approximately 3 x 105 independent clones (of which 85% contained recombinant inserts), was amplified by plating on E. coli Y1088.
Immunoscreening of cDNA library
The R2 antiserum was preabsorbed with a lysate of E. coli Y1090 for 2-3 h at 20°C to reduce binding to E. coli antigens. About I05 phage were screened with R2 using a Promega Protoblot immunoscreening kit. Positives were purified to homogeneity by two further rounds of rescreening.
Amplification and excision of cDNA inserts Recombinant inserts were excised, purified and amplified from single plaques by means of PCR. From the equivalent of 1/4 of a plaque, 1-2 jLg of insert was obtained using 1 jLm each of a pair of primers homologous to sequences flanking the EcoRl insertion site within the lac Z gene of lambda gtl 1, as described by Saiki & colleagues (Saiki et al., 1988) .
The PCR products were digested with EcoRl to remove the short lac Z flanking sequences, and purified by electrophoresis on low melting agarose gels containing ethidium bromide. Bands were excised and after appropriate dilution (Feinberg & Vogelstein, 1983) with H20 the cDNA was stored at -20°C. For subcloning, the cDNA was extracted from the agarose by the glass powder method using the Geneclean Kit (Stratagene).
RNA extraction and hybridisation Total cellular RNA was extracted from frozen tissues using the guanidinium isothiocyanate procedure (Chirgwin et al., 1979) , and from cultured cells by the modified RNA-Zol (Biogenesis, UK) method described previously .
Northern analysis was performed by electrophoresis of total RNA (20jg per lane) denatured by the glyoxylation method (Maniatis et al., 1982) and capillary transfer to Hybond N or N + membranes (Amersham, UK).
Hybridisations were performed using standard protocols ; cDNA probes were labelled directly in low melting agarose using the random primer technique (Feinberg & Vogelstein, 1983) Screening of lambda plaques transferred to Hybond N membranes with 32P-labelled cDNA was performed using established protocols (Benton & Davies, 1977) . DNA sequencing Geneclean purified cDNA was ligated into M 13. Single str4nded templates were subjected to sequencing by the dideoxy chain termination procedure (Veira & Messing, 1982) immunogen produced an antisera which at 1:25,000 dilution still retained 27% of its maximal activity against HMFGM in an ELISA. When tested against CHO-HMFGM we observed a binding capacity of two orders of magnitude greater than that seen with the CHO' membranes. On Western blots R2 showed extensive reactivity with several discrete bands up to approximately 150 Mr (data not shown).
In an immunohistochemical screen, we observed a strong reaction to the epithelial component of both normal breast and primary breast carcinomas. Epithelial cells of skin also showed strong reactivity as did several other tissues (data not shown).
Screening of cDNA library
Approximately IO' pfu from the lambda gtl 1 library were screened with the R2 antiserum. The initial 38 isolates were reduced to 20 positive clones on subsequent rescreenings.
The cDNA inserts from these were amplified by the PCR technique and gel purified EcoRl digested cDNA's were used for cross hybridisation to plaques of the 20 clones. This process of elimination yielded eight independent clones whose PCR products showed approximate sizes of 1350bp (JI), 350bp (J8), 310bp (J16), 650bp (J31) (Figure 1 ) and 60bp (Jll, J14, J28, J35). The four larger clones were taken for further analysis. Partial sequence data were obtained for these and using computer assisted homology searches of the EMBL data banks, we found no significant homologies for JI and J8. The J31 clone showed identity with human immunoglobulin kappa light chain variable region (V-J) and the C terminal region. The 240 bases determined for the J16 clone were entirely homologous to the 3' coding region (position 580-819) of the human lactoferrin gene (Rado et al., 1987; Metz-Boutigue et al., 1984) . This was investigated in more detail.
Expression of the J16 clone in breast tissue In all cases where J16 was expressed, we observed a single invariant band corresponding to a message size of approximately 2.5 kb. The greatest levels of J16 mRNA were detected in lactating breast, but it was also highly expressed in non-lactating normal breast tissue (Figure 2 ). Hybridisation was seen in biopsies, from 15/19 patients, taken from tissue adjacent to carcinoma. RNA extracted from organoid preparations from three separate reduction mammoplasties also has high levels of J16.
To determine whether J 16 was expressed in cancer, we examined 59 primary breast tumours. Forty-four per cent of these had no detectable message. The other 56% showed (Table I) . We also examined the relationship between J16 hybridisation and previously measured transforming growth factor(TGF) alpha and epidermal growth factor receptor (EGFR) mRNA levels (Travers et al., 1988) . In a group of 24 tumours we found that 8/16 which were TGFalpha positive were also J16 positive whereas only 2/8 of the TGF alpha negative ones had J16 expressed. Similarly, a higher proportion (7/13) of EGFR positive tumours expressed J16 than did EGFR negative ones (3/10). Due to the small numbers, statistical significance was not achieved.
Immunocytochemistry with antisera to lactoferrin Strong immunoreactivity was observed in sections of lactating breast. The glandular epithelia were homogeneously stained, as well as the ductal secretions (Figure 4a labelled J16 cDNA. Autoradiography was performed using Hyperfilm at -70C with intensifying screens; 12 day exposure. All tracks except seven (organoid from normal breast mammoplasty) contained RNA from primary breast tumours. The positions of the rRNA are indicated. (Stampfer & Bartley, 1985) . We could not detect J16 expression in any of these lines in 20 .g of total RNA using conditions of probe specific activity and hybridisation identical to those for the tissue RNA. We also examined 45 cases with DCIS, which usually appeared as a relatively small component within most sections. In four of these, we observed some infiltrating carcinoma whilst the remainder were purely DCIS, and showed no invasive components in the sections examined: the former were therefore excluded.
Twenty showed some degree of lactoferrin immunoreactivity. The clinical details of these are given in Table II . The breakdown of the various histological subtypes is shown in Table III . Where present in pure form, the greatest frequency of positivity, and also intensity, was observed in the micropapillary variant (9/11) with least in the cribriform DCIS (3/14) and in 1/3 solid or comedo sub-types. In those tumours where we found more than one sub-type, 80% of those containing any micropapillary DCIS were positive. A higher proportion of both cribriform and solid DCIS were positive: four out of the five positive cribriform DCIS had micropapillary DCIS as the other component. Examples of the staining pattern are illustrated in Figure 6 . Following various surgical treatments, 14/41 (34%) patients developed recurrent disease up to the time of follow up; six developed invasive carcinoma and eight recurrent DCIS (Table IV) . There did not appear to be any relationship between lactoferrin staining and recurrence.
Breast cell lines
We prepared RNA from a number of commonly used breast cancer cell lines, MCF7, T47D, ZR75, MDA231; from HBL 100 and an SV40 transformed line HBrSV1.6.1 which display some 'normal' characteristics; and from 1 84AI and 1 84B5 derived from organoid culture of reduction mammoplasties b Figure 6 Sections showing focal cytoplasmic immunoperoxidase reaction with anti-lactoferrin in DCIS, of the small cell cribriform/micropapillary, a, or mixed solid and comedo, b, variants. In the latter, the unfilled arrow points to positive tumour cells in solid DCIS, and the filled arrows show the necrotic centres and a few surrounding intact cells in a focus of comedo carcinoma. Figure 7 . A high level of hybridisation was seen in the sample from normal stomach. The band intensity was as great as any signal observed from a non-lactating breast specimen. A faint band was discernible in the track containing RNA from skin; a similar signal was also observed with a preparation of lymphocytes (data not shown); no J16 mRNA was detected in placenta, spleen, muscle, lung, kidney, bladder, ovary, colon, thyroid or adrenal gland. These Northern blots were re-hybridised with other commonly expressed clones also isolated from the library and strongly positive signals were obtained in all the tracks, confirming that lack of J16 hybridisation was not due to insufficient RNA in the tracks: we cannot exclude expression at levels below our limits of detection in these experiments. In view of the positivity seen in the normal stomach specimen, we screened five gastric cancer cell lines of various parental lineages and displaying quite different morphological characteristics (Motoyama & Watanabe, 1983; Motoyama et al., 1986) . No hybridisation was detected in any of these lines KATO 111, SCH) .
Discussion
We report a detailed description of the expression of lactoferrin mRNA and protein in human breast tissues. We have found that (a), lactoferrin is present in a subset of normal, malignant and in situ carcinomas and (b), in carcinomas, lactoferrin mRNA is present predominantly in the ER negative tissues.
The J16 clone is homologous to the 3' terminus of the lactoferrin sequence, which encodes a single glycosylated polypeptide of -70-80,000 Mr (Teng et al., 1986) which like transferrin has iron binding properties, and has been found in human (Sanchez-Pozo et al., 1986; Hegnhj et al., 1986) exocrine secretions, and has been isolated from milk and neutrophilic leucocytes (Moguilevsky et al., 1985) . A mouse cDNA clone was isolated form a uterine lambda gtl 1 library by immunoscreening and was found to have -70% homology with the human sequence (Metz-Boutigue et al., 1984) recently cloned from a myeloid library using an oligonucleotide (Rado et al., 1987) . The latter authors found that its expression coincided with granulocytic differentiation.
The distribution of lactoferrin, studied mainly by immunological methods appears to vary considerably between species (Teng et al., 1989; Masson & Heremans, 1966; Roberts & Boursnell, 1975) with conflicting data that presumably reflects both experimental sensitivity (Pentecoste et al., 1987; Teng et al., 1989) and hormonal status of certain tissues. A 300-fold induction with oestrogen was observed in mouse uterus with virtually undetectable amounts in the rat organ (Pentecoste et al., 1987) . Mouse mammary lactoferrin is reported to be unaffected by circulating oestrogen (Teng et al., 1989) but is inducible by prolactin using explants from mid-pregnant mice (Green & Pastewka, 1978) .
Our results have shown that lactoferrin, highly expressed during lactation, is also synthesised by non-lactating breast, primarily by the ductal cells, these being the predominant components of organoids with little stromal contribution. This was confirmed by our immunocytochemical data: Immunoreactivity was associated with actively secreting cells in both lactating and resting ducts. To our knowledge this is Figure 7 Northern blot of RNA extracted from different human tissues; tracks 1-12 contain 20 tg of glyoxal denatured RNA from placenta, spleen, muscle, lung, kidney, bladder, ovary, colon, stomach, adrenal gland, thyroid and skin respectively. Track 13 shows the positions of the rRNA markers. Electrophoresis, blotting and hybridisation with 32P-labelled J16 cDNA was performed as described under Methods. Autoradiographic exposure was for 5 days.
the first systematic study of lactoferrin mRNA expression in malignancy. Although patchy, foci of tumour cells were clearly positive, confirming that RNA hybridisation observed in tumour biopsies was not due exclusively to contaminating normal elements. No obvious clinical correlate was found and more tumours are being examined before meaningful statistical analysis can be performed. The frequency of positivity reported here is in line with the immunocytochemical data of Wurster et al. (1980) and Wrba et al. (1986) and it is clear that lactoferrin cannot be considered as a marker of benign lesions as suggested by Rossiello et al. (1984) . Of the five positive cases reported by Charpin et al. (1985) , two were DCIS. We found lactoferrin in similar proportions of both invasive and DCIS tumours.
J16 hybridisation tended to be more associated with invasive tumours lacking ER. Expression was also more prevalent in tumours which were TGFalpha positive and to a lesser extent in those that were EGFR positive, compared to those which were negative for either factor. An inverse correlation between ER and EGFR has been commonly observed (Sainsbury et al., 1987; Travers et al., 1988) and we have also shown that TGFalpha transcripts are more expressed in ER negative cancers and that there is a significant coexpression of TGFalpha and EGFR which is also more prevalent in the ER negative tumours (Travers et al., 1988) .
ER status is sometimes used to select patients for endocrine therapy. The presence of lactoferrin mRNA may be an additional confirmatory factor in choosing to provide alternative treatment for ER negative patients. The tissue screen showed a selective distribution with high expression only in normal stomach in agreement with Mason and Taylor (1978) .
Again, it is interesting that no expression was seen in the gastric cell lines; we are currently examining a series of stomach carcinomas. The lack of expression in spleen, lung, kidney and ovary is in contrast to the findings in the corresponding mouse tissues by Western blotting (Tend et al., 1989) ; a similar discordance exists with duodenum between mouse and human tissue (Teng et al., 1989; Mason & Taylor, 1978) . For kidney and ovary there was some doubt as to the authenticity of the 65 Mr band (Tend et al., 1989) in these studies, compared to the 70 Mr protein described earlier (Teng et al., 1986) . It remains to be seen whether these reported differences reflect true species variability.
Few human tissues (haematopoietic cells aside) are convincingly positive, with reports of lactoferrin in secretory phase endometrium (Tourville et al., 1970) and in seminal plasma (Goodman & Young, 1981) as a major sperm-coating antigen (Heckman & Rumke, 1969) . Immunocytochemical staining has been reported (Mason & Taylor, 1978) in gastric mucus neck cells, some duodenal absorptive epithelia, glandular bronchial glands and most strongly in glandular epithelia (and their secretions) of lactating breast; also in the odd sample of uterus and a basal cell skin carcinoma. An extensive study (Hulseweische et al., 1989) of gastric tumours showed lactoferrin expression in biopsies associated with inflammation, but its absence was noted from mucoepidermoid carcinomas (Kumasa et al., 1988) .
